< Back to previous page
Publication
Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma : results from two phase 3, randomised, double-blind, placebo-controlled trials
Journal Contribution - Journal Article
Journal: LANCET RESPIRATORY MEDICINE
ISSN: 2213-2600
Issue: 5
Volume: 8
Pages: 461 - 474
Publication year:2020
Accessibility:Closed